Clorox (CLX) Notes Payables (2009 - 2026)

Clorox's Notes Payables history runs 16 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• On a quarterly basis, Notes Payables rose 2846.3% year-over-year to $1.6 billion in Q1 2026; TTM through Mar 2026 was $1.6 billion, a 2846.3% increase from a year earlier, with the FY2025 full-year figure at $4.0 million, changed 0.0% from the prior year.
• Notes Payables improved to $1.6 billion in Q1 2026 per CLX's latest filing, from $307.0 million in the prior quarter.
• Across five years, Notes Payables topped out at $1.6 billion in Q1 2026 and bottomed at $4.0 million in Q2 2024.
• The 5-year median for Notes Payables is $209.0 million (2022), against an average of $261.9 million.
• Across the five-year window, Notes Payables slumped 98.85% in 2024 and jumped 5350.0% in 2025, its largest moves.
• Year by year, Notes Payables stood at $209.0 million in 2022, then increased by 18.18% to $247.0 million in 2023, then retreated by 23.48% to $189.0 million in 2024, then jumped by 62.43% to $307.0 million in 2025, then jumped by 418.24% to $1.6 billion in 2026.
• Per Business Quant, the three latest CLX Notes Payables figures stand at $1.6 billion (Q1 2026), $307.0 million (Q4 2025), and $218.0 million (Q3 2025).